Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links

Drugs

-

Xyrem (sodium oxybate) Information

Xyrem (sodium oxybate) is approved to reduce attacks of muscle weakness (cataplexy) and treat daytime sleepiness in patients with narcolepsy.

To report any serious adverse events associated with the use of this drug, please contact the FDA MedWatch program.

-

Related Information

FDA Drug Safety Communication: Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression
12/17/2012
Comunicado de la FDA sobre la seguridad de los medicamentos: Advertencia sobre el uso de Xyrem (oxibato de sodio) con bebidas alcohólicas o medicamentos ya que puede causar depresión respiratoria
FDA Drug Safety Podcast: Warning against use of Xyrem (sodium oxybate) with alcohol or drugs causing respiratory depression

-

-

Regulatory History and Labeling from Drugs@FDA

Xyrem (sodium oxybate) regulatory history and labeling

-

-

-